Israel approved, on Tuesday, the use of the anti-viral drug Remedisfer, which is produced by the American company, “Gilead Sciences”, to treat “Covid-19” disease caused by the Coruna virus.
RemedySever is the first drug shown in human trials to be effective against the emerging corona virus.
Prime Minister Benjamin Netanyahu’s office said in a statement that the cabinet approved a request by the Minister of Health to accept Gilead’s donation of “Remisevir” and that it would be used in the treatment of patients with moderate and critical conditions.
Israel recorded 19,338 cases and 302 deaths of “Covid-19” and has witnessed a rise in new cases of the disease since it reopened schools, restaurants and many companies last month.
South Korea, Japan, India, the United States and Singapore have already agreed to use it for emergency treatment.
Clinical trials of the drug “Remdisevir” are closely monitored, with countries searching for a cure for the disease, which has been reported to have infected more than 8 million people and claimed more than 400,000 lives worldwide.